SCHEMBL18010941

SCHEMBL18010941

CC1(C)OC[C@H](Cl)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18010942 1.00
SCHEMBL28868554 0.74 CA2 (0.32)
SCHEMBL1980377 0.72
SCHEMBL12060575 0.71 CA2 (0.39)
SCHEMBL6304664 0.69
SCHEMBL2540229 0.69
SCHEMBL243965 0.69
SCHEMBL2480054 0.69
SCHEMBL1204186 0.67
SCHEMBL1077396 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3061747-B1 PYRIDIC KETONE DERIVATIVES, METHOD OF PREPARING SAME, AND PHARMACEUTICAL APPLICATION THEREOF Shanghai hengrui pharmaceutical co ltd (CN) 2021-04-07 EP disclosed
US-10064848-B2 Pyridic ketone derivatives, method of preparing same, and pharmaceutical application thereof SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD. (CN) 2018-09-04 US disclosed
US-9914703-B2 Pyridic ketone derivatives, method of preparing same, and pharmaceutical application thereof SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD. (CN) 2018-03-13 US disclosed
US-20180016236-A1 PYRIDIC KETONE DERIVATIVES, METHOD OF PREPARING SAME, AND PHARMACEUTICAL APPLICATION THEREOF SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD. (CN) 2018-01-18 US disclosed
EP-3061747-A1 PYRIDIC KETONE DERIVATIVES, METHOD OF PREPARING SAME, AND PHARMACEUTICAL APPLICATION THEREOF Shanghai Hengrui Pharmaceutical Co. Ltd. (CN) 2016-08-31 EP disclosed
US-20160244410-A1 PYRIDIC KETONE DERIVATIVES, METHOD OF PREPARING SAME, AND PHARMACEUTICAL APPLICATION THEREOF SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD. (CN) 2016-08-25 US disclosed